{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:54:41Z","timestamp":1792076081095,"version":"4.4.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Preterm birth-related complications are the leading cause of death in newborns and children under 5. Health outcomes of preterm newborns can be improved with appropriate use of antenatal corticosteroids (ACSs) to promote fetal lung maturity, tocolytics to delay birth, magnesium sulphate for fetal neuroprotection, and antibiotics for preterm prelabour rupture of membranes. However, there are wide disparities in the rate and consistency in the use of these interventions across settings, which may underlie the differential health outcomes among preterm newborns. We aimed to assess factors (barriers and facilitators) affecting the appropriate use of ACS, tocolytics, magnesium sulphate, and antibiotics to improve preterm birth management.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We conducted a mixed-methods systematic review including primary qualitative, quantitative, and mixed-methods studies. We searched MEDLINE, EMBASE, CINAHL, Global Health, and grey literature from inception to 16 May 2022. Eligible studies explored perspectives of women, partners, or community members who experienced preterm birth or were at risk of preterm birth and\/or received any of the 4 interventions, health workers providing maternity and newborn care, and other stakeholders involved in maternal care (e.g., facility managers, policymakers). We used an iterative narrative synthesis approach to analysis, assessed methodological limitations using the Mixed Methods Appraisal Tool, and assessed confidence in each qualitative review finding using the GRADE-CERQual approach. Behaviour change models (Theoretical Domains Framework; Capability, Opportunity, and Motivation (COM-B)) were used to map barriers and facilitators affecting appropriate use of these interventions. We included 46 studies from 32 countries, describing factors affecting use of ACS (32\/46 studies), tocolytics (13\/46 studies), magnesium sulphate (9\/46 studies), and antibiotics (5\/46 studies). We identified a range of barriers influencing appropriate use of the 4 interventions globally, which include the following: inaccurate gestational age assessment, inconsistent guidelines, varied knowledge, perceived risks and benefits, perceived uncertainties and constraints in administration, confusion around prescribing and administering authority, and inadequate stock, human resources, and labour and newborn care. Women reported hesitancy in accepting interventions, as they typically learned about them during emergencies. Most included studies were from high-income countries (37\/46 studies), which may affect the transferability of these findings to low- or middle-income settings.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study, we identified critical factors affecting implementation of 4 interventions to improve preterm birth management globally. Policymakers and implementers can consider these barriers and facilitators when formulating policies and planning implementation or scale-up of these interventions. Study findings can inform clinical preterm birth guidelines and implementation to ensure that barriers are addressed, and enablers are reinforced to ensure these interventions are widely available and appropriately used globally.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004074","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T17:39:04Z","timestamp":1661276344000},"page":"e1004074","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-2336","authenticated-orcid":true,"given":"Rana Islamiah","family":"Zahroh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-0245","authenticated-orcid":true,"given":"Alya","family":"Hazfiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-4746","authenticated-orcid":true,"given":"Katherine E.","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-7096","authenticated-orcid":true,"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5370-682X","authenticated-orcid":true,"given":"\u04e6zge","family":"Tun\u00e7alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Minckas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-8701","authenticated-orcid":true,"given":"Fernando","family":"Althabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-5892","authenticated-orcid":true,"given":"Olufemi T.","family":"Oladapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-4682","authenticated-orcid":true,"given":"Meghan A.","family":"Bohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"pmed.1004074.ref001","author":"World Health Organization","year":"2018","journal-title":"Preterm birth. World Health Organization"},{"key":"pmed.1004074.ref002","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","article-title":"Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis","volume":"7","author":"S Chawanpaiboon","year":"2019","journal-title":"Lancet Glob Health"},{"key":"pmed.1004074.ref003","first-page":"CD006764","article-title":"Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth","author":"FC Brownfoot","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3476(96)70384-0","article-title":"Extrapulmonary effects of antenatally administered steroids","volume":"128","author":"JF Padbury","year":"1996","journal-title":"J Pediatr"},{"key":"pmed.1004074.ref005","first-page":"355","article-title":"Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials","author":"G Saccone","year":"2016","journal-title":"BMJ"},{"key":"pmed.1004074.ref006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"GC Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"pmed.1004074.ref007","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"E McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref008","first-page":"CD004352","article-title":"Betamimetics for inhibiting preterm labour.","author":"JP Neilson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref009","first-page":"CD002255","article-title":"Calcium channel blockers for inhibiting preterm labour and birth.","volume":"2014","author":"V Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref010","first-page":"CD004661","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"LW Doyle","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref011","first-page":"CD000246","article-title":"Prophylactic antibiotics for inhibiting preterm labour with intact membranes","author":"V Flenady","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004074.ref012","volume-title":"WHO recommendations on interventions to improve preterm birth outcomes","author":"World Health Organization","year":"2015"},{"key":"pmed.1004074.ref013","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S2214-109X(15)00183-7","article-title":"New WHO recommendations to improve the outcomes of preterm birth","volume":"3","author":"JP Vogel","year":"2015","journal-title":"Lancet Glob Health"},{"key":"pmed.1004074.ref014","article-title":"Antenatal Corticosteroid Therapy for Fetal Maturation","author":"The American College of Obstetricians and Gynecologists","year":"2017"},{"key":"pmed.1004074.ref015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijgo.13836","article-title":"FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm","volume":"155","author":"Birth the FWG for P","year":"2021","journal-title":"Obstet Gynecol Int J"},{"key":"pmed.1004074.ref016","author":"Antenatal Corticosteroid Clinical Practice Guidelines Panel","year":"2015"},{"key":"pmed.1004074.ref017","article-title":"Quality statement 5: Corticosteroids for women between 24+0 and 33+6 weeks of pregnancy | Preterm labour and birth | Quality standards | NICE.","author":"The National Institute for Health and Care Excellence","year":"2019","journal-title":"The National Institute for Health and Care Excellence"},{"key":"pmed.1004074.ref018","article-title":"Quality statement 6: Magnesium sulfate for women between 24+0 and 29+6 weeks of pregnancy | Preterm labour and birth | Quality standards | NICE.","author":"The National Institute for Health and Care Excellence","year":"2019","journal-title":"The National Institute for Health and Care Excellence"},{"key":"pmed.1004074.ref019","volume-title":"Magnesium Sulphate for Neuroprotection of the Fetus in Women at Risk of Preterm Birth: South Australian Perinatal Practice Guideline","author":"Department for Health and Wellbeing, Government of South Australia","year":"2020"},{"key":"pmed.1004074.ref020","article-title":"Green-top Guideline No. 44\u2014Preterm Prelabour Rupture of Membranes.","author":"Royal College of Obstetricians and Gynaecologists.","year":"2010","journal-title":"Royal College of Obstetricians and Gynaecologists"},{"key":"pmed.1004074.ref021","first-page":"245","article-title":"ACOG Guidelines on Premature Rupture of Membranes","volume":"77","author":"C. Armstrong","year":"2008","journal-title":"Aust Fam Physician"},{"key":"pmed.1004074.ref022","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2393-15-S2-S3","article-title":"Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions.","volume":"15","author":"G Liu","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12884-015-0618-9","article-title":"Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework","volume":"15","author":"E Bain","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0002-9378(95)90220-1","article-title":"An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids","volume":"173","author":"LC Leviton","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004074.ref025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"L Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"pmed.1004074.ref026","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"S Michie","year":"2011","journal-title":"Implement Sci"},{"key":"pmed.1004074.ref027","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"2021","author":"MJ Page","journal-title":"BMJ"},{"key":"pmed.1004074.ref028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ.","volume":"12","author":"A Tong","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"pmed.1004074.ref029","article-title":"EPOC Qualitative Evidence Synthesis: Protocol and review template. Version 1.1.","author":"C Glenton","year":"2020","journal-title":"EPOC Resources for review authors"},{"key":"pmed.1004074.ref030","first-page":"285","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"QN Hong","year":"2018","journal-title":"Educ Inf."},{"key":"pmed.1004074.ref031","author":"J Popay","year":"2006"},{"key":"pmed.1004074.ref032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews.","volume":"8","author":"J Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"pmed.1004074.ref033","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1464-0597.2008.00341.x","article-title":"From Theory to Intervention: Mapping Theoretically Derived Behavioural Determinants to Behaviour Change Techniques.","volume":"57","author":"S Michie","year":"2008","journal-title":"Appl Psychol"},{"key":"pmed.1004074.ref034","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13012-017-0688-3","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series","volume":"13","author":"S Lewin","year":"2018","journal-title":"Implement Sci."},{"key":"pmed.1004074.ref035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13012-017-0689-2","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 2: how to make an overall CERQual assessment of confidence and create a Summary of Qualitative Findings table","volume":"13","author":"S Lewin","year":"2018","journal-title":"Implement Sci."},{"key":"pmed.1004074.ref036","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13012-017-0690-9","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 3: how to assess methodological limitations.","volume":"13","author":"H Munthe-Kaas","year":"2018","journal-title":"Implement Sci."},{"key":"pmed.1004074.ref037","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13012-017-0691-8","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 4: how to assess coherence","volume":"13","author":"CJ Colvin","year":"2018","journal-title":"Implement Sci"},{"key":"pmed.1004074.ref038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13012-017-0692-7","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2014paper 5: how to assess adequacy of data","volume":"13","author":"C Glenton","year":"2018","journal-title":"Implement Sci"},{"key":"pmed.1004074.ref039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13012-017-0693-6","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2013paper 6: how to assess relevance of the data","volume":"13","author":"J Noyes","year":"2018","journal-title":"Implement Sci."},{"key":"pmed.1004074.ref040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmjqs-2015-003984","article-title":"Reliable implementation of evidence: a qualitative study of antenatal corticosteroid administration in Ohio hospitals","volume":"25","author":"HC Kaplan","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"pmed.1004074.ref041","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/jp.2014.175","article-title":"The influence of resuscitation preferences on obstetrical management of periviable deliveries","volume":"35","author":"BT Edmonds","year":"2015","journal-title":"J Perinatol"},{"key":"pmed.1004074.ref042","doi-asserted-by":"crossref","first-page":"398.e1","DOI":"10.1016\/j.ajog.2015.05.005","article-title":"Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals","volume":"213","author":"SZ Bousleiman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004074.ref043","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1080\/14767058.2019.1566307","article-title":"Management of diabetic women with threatened preterm birth: a survey of Maternal-Fetal Medicine providers.","volume":"33","author":"AN Battarbee","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"pmed.1004074.ref044","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9378(87)80335-6","article-title":"Management of preterm premature rupture of membranes: lack of a national consensus.","volume":"157","author":"EL Capeless","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004074.ref045","first-page":"336","article-title":"Variations between family physicians and obstetricians in the evaluation and treatment of preterm labor","volume":"45","author":"WJ Hueston","year":"1997","journal-title":"J Fam Pract"},{"key":"pmed.1004074.ref046","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1667028","article-title":"Practice Variation in Antenatal Steroid Administration for Anticipated Late Preterm Birth: A Physician Survey","volume":"36","author":"AN Battarbee","year":"2019","journal-title":"Am J Perinatol."},{"key":"pmed.1004074.ref047","first-page":"140","article-title":"Obstetrician-gynecologists\u2019 knowledge and training about antenatal corticosteroids","volume":"97","author":"K Erickson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"pmed.1004074.ref048","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/982060","article-title":"Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes.","volume":"13","author":"NE Glass","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"key":"pmed.1004074.ref049","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/jp.2014.213","article-title":"Comparing obstetricians\u2019 and neonatologists\u2019 approaches to periviable counseling","volume":"35","author":"B Tucker Edmonds","year":"2015","journal-title":"J Perinatol"},{"key":"pmed.1004074.ref050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/jp.2014.201","article-title":"A national survey of obstetricians\u2019 attitudes toward and practice of periviable intervention.","volume":"35","author":"B Tucker Edmonds","year":"2015","journal-title":"J Perinatol"},{"key":"pmed.1004074.ref051","unstructured":"Kalb KA. Women\u2019s experiences using terbutaline pump therapy for the management of preterm labor. PhD Dissertation. University of Minnesota; 1993."},{"key":"pmed.1004074.ref052","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1701-2163(16)30625-9","article-title":"Multiple versus single courses of antenatal corticosteroids for preterm birth: a pilot study.","volume":"24","author":"F Aghajafari","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"pmed.1004074.ref053","doi-asserted-by":"crossref","first-page":"671.e1","DOI":"10.1016\/j.ajog.2014.12.031","article-title":"Current practices in the prediction and prevention of preterm birth in patients with higher-order multiple gestations","volume":"212","author":"E Baker","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004074.ref054","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1701-2163(16)32384-2","article-title":"Preterm labour and birth: a survey of clinical practice regarding use of tocolytics, antenatal corticosteroids, and progesterone","volume":"29","author":"D Hui","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"pmed.1004074.ref055","first-page":"291","article-title":"Prenatal corticosteroids. Use and attitudes of the gynecology-obstetrics medical staff","volume":"68","author":"A Vargas-Origel","year":"2000","journal-title":"Ginecol Obstet Mex"},{"key":"pmed.1004074.ref056","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4755-10-4","article-title":"Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices","volume":"10","author":"A Aleman","year":"2013","journal-title":"Reprod Health."},{"key":"pmed.1004074.ref057","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1479-828X.2004.00256.x","article-title":"Preterm prelabour rupture of the membranes: a survey of current practice.","volume":"44","author":"S Buchanan","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref058","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajo.12008","article-title":"Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand","volume":"53","author":"WISH Project Team","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref059","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1479-828X.2004.00173.x","article-title":"Survey of the management of preterm labour in Australia and New Zealand in 2002.","volume":"44","author":"C-M Cook","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ajo.12981","article-title":"Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand\u2014Ongoing barriers and enablers.","volume":"60","author":"K Gatman","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ajo.12564","article-title":"Investigating antenatal corticosteroid clinical guideline practice at an organisational level","volume":"57","author":"EL McGoldrick","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref062","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12884-016-1043-4","article-title":"Consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines","volume":"16","author":"EL McGoldrick","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref063","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12913-016-1858-8","article-title":"Identifying the barriers and enablers in the implementation of the New Zealand and Australian Antenatal Corticosteroid Clinical Practice Guidelines.","volume":"16","author":"EL Mc Goldrick","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"pmed.1004074.ref064","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1479-828X.1989.tb02866.x","article-title":"New Zealand obstetricians\u2019 management of hypertension in pregnancy. A questionnaire survey","volume":"29","author":"JD Hutton","year":"1989","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"pmed.1004074.ref065","first-page":"7","article-title":"Resident Quality Improvement Project: Antenatal Magnesium Sulfate Protocol for Fetal Neuroprotection in Preterm Births","author":"JAX Hong","year":"2017","journal-title":"Obstet Gynecol Int J."},{"key":"pmed.1004074.ref066","first-page":"45","article-title":"Study of stress and coping behaviors in families of hospitalized pregnant woman undergoing tocolysis","volume":"53","author":"Y-L Hu","year":"2006","journal-title":"Hu Li Za Zhi"},{"key":"pmed.1004074.ref067","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.JNR.0000387563.49565.22","article-title":"The lived experience of first-time expectant fathers whose spouses are tocolyzed in hospital","volume":"14","author":"Y-H Hsieh","year":"2006","journal-title":"J Nurs Res"},{"key":"pmed.1004074.ref068","first-page":"682","article-title":"Providing antenatal corticosteroids for preterm birth: a quality improvement initiative in Cambodia and the Philippines.","volume":"28","author":"JM Smith","year":"2016","journal-title":"Int J Qual Health Care"},{"key":"pmed.1004074.ref069","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejogrb.2006.01.012","article-title":"Staff views on the management of the extremely preterm infant","volume":"128","author":"KL Chan","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pmed.1004074.ref070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/oxfordjournals.intqhc.a002609","article-title":"The Leeds University Maternity Audit Project","volume":"14","author":"B Wilson","year":"2002","journal-title":"Int J Qual Health Care"},{"key":"pmed.1004074.ref071","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1471-0528.2010.02661.x","article-title":"Has publication of the results of the ORACLE Children Study changed practice in the UK?","volume":"117","author":"S Kenyon","year":"2010","journal-title":"BJOG"},{"key":"pmed.1004074.ref072","doi-asserted-by":"crossref","first-page":"e000189","DOI":"10.1136\/bmjoq-2017-000189","article-title":"Preventing cerebral palsy in preterm labour: a multiorganisational quality improvement approach to the adoption and spread of magnesium sulphate for neuroprotection","volume":"6","author":"A Burhouse","year":"2017","journal-title":"BMJ Open Qual"},{"key":"pmed.1004074.ref073","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11845-010-0604-1","article-title":"Practices for predicting and preventing preterm birth in Ireland: a national survey.","volume":"180","author":"V Smith","year":"2011","journal-title":"Ir J Med Sci"},{"key":"pmed.1004074.ref074","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1016\/j.midw.2011.10.009","article-title":"Attitudes of Swedish midwives towards management of extremely preterm labour and birth","volume":"28","author":"M Danerek","year":"2012","journal-title":"Midwifery"},{"key":"pmed.1004074.ref075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12884-017-1489-z","article-title":"Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey","volume":"17","author":"C Chollat","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref076","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/1471-0528.16039","article-title":"Do obstetricians apply the national guidelines? A vignette-based study assessing practices for the prevention of preterm birth","volume":"127","author":"A Rousseau","year":"2020","journal-title":"BJOG"},{"key":"pmed.1004074.ref077","first-page":"307","article-title":"Changing Physician\u2019s Practice on Antenatal Corticosteroids in Preterm Birth.","volume":"88","author":"P. Saengwaree","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"pmed.1004074.ref078","doi-asserted-by":"crossref","first-page":"575","DOI":"10.9745\/GHSP-D-20-00716","article-title":"Readiness to Provide Antenatal Corticosteroids for Threatened Preterm Birth in Public Health Facilities in Northern India","volume":"9","author":"A Kankaria","year":"2021","journal-title":"Glob Health Sci Pract"},{"key":"pmed.1004074.ref079","doi-asserted-by":"crossref","first-page":"644","DOI":"10.9745\/GHSP-D-18-00171","article-title":"Antenatal Corticosteroids for Women at Risk of Imminent Preterm Birth in 7 sub-Saharan African Countries: A Policy and Implementation Landscape Analysis","volume":"6","author":"D Greensides","year":"2018","journal-title":"Glob Health Sci Pract"},{"key":"pmed.1004074.ref080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJWH.S185199","article-title":"Qualitative assessment of knowledge transfer regarding preterm birth in Malawi following the implementation of targeted health messages over 3 years.","volume":"11","author":"KM Antony","year":"2019","journal-title":"Int J Women\u2019s Health"},{"key":"pmed.1004074.ref081","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2393-14-123","article-title":"Qualitative assessment of attitudes and knowledge on preterm birth in Malawi and within country framework of care","volume":"14","author":"J Levison","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref082","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12884-015-0785-8","article-title":"Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada.","volume":"15","author":"KC Teela","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004074.ref083","unstructured":"World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience 2022. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241549912 [cited 2021 Dec 12]."},{"key":"pmed.1004074.ref084","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMoa2022398","article-title":"Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.","author":"WHO ACTION Trials Collaborators","year":"2020","journal-title":"N Engl J Med"},{"key":"pmed.1004074.ref085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13063-019-3488-z","article-title":"The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries","volume":"20","author":"R Bahl","year":"2019","journal-title":"Trials"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004105","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T17:40:04Z","timestamp":1661276404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004074"}},"subtitle":[],"editor":[{"given":"Sarah J.","family":"Stock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":85,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004074","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pmed.1004105","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]}}}